SCHEMBL4523167

SCHEMBL4523167

Cc1cccc(C)c1C1CCN(Cc2c(C(=O)N3CCC(N4CCCCC4)CC3)[nH]c3ccccc23)CC1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 2/20 0.51
L3MBTL3 Q96JM7 4/20 0.43
L3MBTL1 Q9Y468 4/20 0.43
MBTD1 Q05BQ5 2/20 0.43
TP53BP1 Q12888 2/20 0.43
ALDH1A1 P00352 3/20 0.42
RGS12 O14924 1/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
MAPT P10636 1/20 0.42
HTT P42858 1/20 0.42
KMT2A Q03164 1/20 0.42
CCR5 P51681 1/20 0.42
LMNA P02545 1/20 0.41
CHRM1 P11229 1/20 0.41
SMYD2 Q9NRG4 1/20 0.40
TLR9 Q9NR96 1/20 0.40
TLR8 Q9NR97 1/20 0.40
TLR7 Q9NYK1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4530667 0.93 KDM4E (0.46) MCL1ALDH1A1KDM4EMEN1MAPT
SCHEMBL4519514 0.93 KDM4E (0.46) MCL1ALDH1A1KDM4EMEN1MAPT
Hydrochloric Acid SCHEMBL4530582 0.92 ALDH1A1 (0.47) MCL1L3MBTL1ALDH1A1RGS12KDM4E
Hydrochloric Acid SCHEMBL4519164 0.92 KDM4E (0.45) MCL1ALDH1A1KDM4EMEN1MAPT
SCHEMBL4510224 0.92 KDM4E (0.46) MCL1ALDH1A1KDM4EMEN1MAPT
SCHEMBL4519426 0.91 MCL1 (0.61) MCL1L3MBTL3L3MBTL1ALDH1A1KDM4E
SCHEMBL4528287 0.90 KDM4E (0.46) MCL1ALDH1A1KDM4EMEN1MAPT
SCHEMBL4505975 0.88 KDM4E (0.45) MCL1ALDH1A1KDM4EMEN1MAPT
SCHEMBL4505463 0.88 MAPT (0.45) MCL1ALDH1A1KDM4EMEN1MAPT
Trifluoroacetic Acid SCHEMBL4521622 0.88 ALDH1A1 (0.43) MCL1L3MBTL1ALDH1A1RGS12KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090275555-A1 Substituted indole ligands for the ORL-1 receptor BRANE DISCOVERY S.R.L. (IT) 2009-11-05 US claimed
EP-1841755-A1 SUBSTITUTED INDOLE LIGANDS FOR THE ORL-1 RECEPTOR BRANE DISCOVERY S.R.L. (IT) 2007-10-10 EP claimed
WO-2006070001-A1 SUBSTITUTED INDOLE LIGANDS FOR THE ORL-1 RECEPTOR BRANE DISCOVERY S.R.L. (IT) 2006-07-06 WO claimed
US-20090275555-A1 Substituted indole ligands for the ORL-1 receptor BRANE DISCOVERY S.R.L. (IT) 2009-11-05 US disclosed
EP-1841755-A1 SUBSTITUTED INDOLE LIGANDS FOR THE ORL-1 RECEPTOR BRANE DISCOVERY S.R.L. (IT) 2007-10-10 EP disclosed
WO-2006070001-A1 SUBSTITUTED INDOLE LIGANDS FOR THE ORL-1 RECEPTOR BRANE DISCOVERY S.R.L. (IT) 2006-07-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275555-A1 Substituted indole ligands for the ORL-1 receptor OGFRL1, OPRL1, ORMDL3 MCL1 1303/4885L3MBTL3 1679/4885L3MBTL1 515/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.